MYRIAD GENETICS INC — Director's Dealing 2019

Aug 2, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2019-08-01

Reporting Person: King Gary A. (Exec. VP International Ops)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-01	Common Stock	M	30000	$26.49	Acquired	164871	Direct
2019-08-01	Common Stock	S	30000	$46.1901	Disposed	134871	Direct
2019-08-01	Common Stock	M	10000	$23.98	Acquired	144871	Direct
2019-08-01	Common Stock	S	10000	$43.4816	Disposed	134871	Direct
2019-08-01	Common Stock	M	20000	$19.47	Acquired	154871	Direct
2019-08-01	Common Stock	S	20000	$39.4405	Disposed	134871	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-08-01	Non-Qualified Stock Option (right to buy)	$19.47	M	20000	Disposed	2021-09-13	Common Stock (20000)	Direct
2019-08-01	Non-Qualified Stock Option (right to buy)	$23.98	M	10000	Disposed	2022-03-07	Common Stock (10000)	Direct
2019-08-01	Non-Qualified Stock Option (right to buy)	$26.49	M	30000	Disposed	2021-09-17	Common Stock (30000)	Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.